BioTime Inc (NYSE American:BTX)

2.60
Delayed Data
As of Feb 16
 -0.05 / -1.89%
Today’s Change
2.10
Today|||52-Week Range
3.62
+20.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues1.1M390.0K381.0K1.7M
 
 
 
 
 
Cost of Goods Sold-20.0K57.0K5.0K52.0K
 
 
 
 
 
Depreciation And Amortization826.0K818.0K787.0K831.0K
 
 
 
 
 
 
Operating ExpensesGross Income277.0K-485.0K-411.0K805.0K
 
 
 
 
 
General Expenses11.5M10.8M9.9M10.3M
 
 
 
 
 
Research And Development6.4M5.9M5.7M6.0M
 
 
 
 
 
Total Operating Expenses12.3M11.7M10.7M11.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-11.3M-10.3M-9.5M
 
 
 
 
 
Extraordinary Charge0.000.000.00-2.8M
 
 
Pre-Tax Equity Earnings4.3M-10.0M-7.7M31.2M
 
 
 
 
 
Interest Expense On Debt234.0K306.0K413.0K10.0K
 
 
 
 
 
Other Expenses-601.0K72.4M2.4M-143.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.7M50.9M-16.1M18.8M
 
 
 
 
 
Income Taxes0.00-3.9M-3.9M-4.8M
 
 
 
 
Minority Interest-2.7M-2.3M-576.0K-335.0K
 
 
 
 
 
Net Income-5.1M49.3M-11.7M14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.8M106.7M110.9M115.3M
 
 
 
 
 
Shares To Calculate EPS Diluted102.8M107.4M110.9M115.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05$0.46-$0.11$0.12
 
 
 
 
 
EPS Diluted-$0.05$0.46-$0.11$0.12